Age-related cataract accounts for approximately 50% of blindness in Africa, affecting an estimated 3.5 million people. 1 It is common practice in many African blindness prevention programmes to ...
The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only ...
DUBLIN--(BUSINESS WIRE)--The "Intraocular Lenses - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...
TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes. 5¶ Experience the ...
Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...
Abbott has earned FDA approval for its Tecnis Symfony Intraocular Lenses for the treatment of cataracts. The approval includes the Tecnis Symfony Toric IOL, a version of the lenses that are made for ...
LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback